These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9263752)

  • 21. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
    Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients.
    Mak RH
    Pediatr Nephrol; 1992 Jul; 6(4):345-8. PubMed ID: 1498003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset.
    Fliser D; Keller C; Bahrmann P; Franek E; Schreckling H; Bergis K; Ritz E
    J Hypertens; 1997 Mar; 15(3):293-9. PubMed ID: 9468457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous calcitriol normalizes insulin sensitivity in uremic patients.
    Kautzky-Willer A; Pacini G; Barnas U; Ludvik B; Streli C; Graf H; Prager R
    Kidney Int; 1995 Jan; 47(1):200-6. PubMed ID: 7731147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five weeks of insulin-like growth factor-I treatment does not alter glucose kinetics or insulin sensitivity during a hyperglycemic clamp in older women.
    Braun B; Friedlander AL; Pollack M; Butterfield GE; Marcus R; Hoffman AR
    Metabolism; 2003 Sep; 52(9):1182-90. PubMed ID: 14506625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.
    Brown SA; Ontjes DA; Lester GE; Lark RK; Hensler MB; Blackwood AD; Caminiti MJ; Backlund DC; Aris RM
    Osteoporos Int; 2003 Jun; 14(5):442-9. PubMed ID: 12774194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of metoprolol treatment on insulin sensitivity and diurnal plasma hormone levels in hypertensive subjects.
    Gudbjörnsdóttir S; Fowelin J; Elam M; Attvall S; Bengtsson BA; Mårin P; Lönnroth P
    Eur J Clin Invest; 1997 Jan; 27(1):29-35. PubMed ID: 9041374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
    Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
    Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal.
    Cooper BC; Sites CK; Casson PR; Toth MJ
    Fertil Steril; 2007 May; 87(5):1131-8. PubMed ID: 17478172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3.
    Allegra V; Luisetto G; Mengozzi G; Martimbianco L; Vasile A
    Nephron; 1994; 68(1):41-7. PubMed ID: 7991039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
    Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
    Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Pulse' oral calcitriol in uraemic patients: rapid modification of parathyroid response to calcium.
    Kwan JT; Almond MK; Beer JC; Noonan K; Evans SJ; Cunningham J
    Nephrol Dial Transplant; 1992; 7(8):829-34. PubMed ID: 1325616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.
    Noor MA; Seneviratne T; Aweeka FT; Lo JC; Schwarz JM; Mulligan K; Schambelan M; Grunfeld C
    AIDS; 2002 Mar; 16(5):F1-8. PubMed ID: 11964551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
    J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term metabolic effects of prednisone administration in healthy subjects.
    Kauh EA; Mixson LA; Shankar S; McCarthy J; Maridakis V; Morrow L; Heinemann L; Ruddy MK; Herman GA; Kelley DE; Hompesch M
    Diabetes Obes Metab; 2011 Nov; 13(11):1001-7. PubMed ID: 21635675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of angiotensin II on insulin sensitivity: a placebo-controlled study.
    Morris AD; Petrie JR; Anderson J; Connell JM; Donnelly R
    Clin Sci (Lond); 1993 Oct; 85(4):431-6. PubMed ID: 8222508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
    Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
    Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.